Skip to main content
Fig. 2 | BMC Research Notes

Fig. 2

From: The relationship between high ratios of CD4/FOXP3 and CD8/CD163 and the improved survivability of metastatic triple-negative breast cancer patients: a multicenter cohort study

Fig. 2

The correlation path analysis between each antitumor and protumor marker towards 1 year OS. OS overall survival. Analyzed using Spearman’s correlation test. Bold indicates a statistically significant correlation. Green lines indicate the path of CD4. Light blue lines indicate the path of CD8. Red lines indicate the path of CD163. Yellow lines indicate the path of FOXP3. Orange lines indicate the correlation either between each antitumor or protumor. Dark blue lines indicate the correlation between antitumor/protumor ratio and 1 year OS

Back to article page